Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
2.50 |
| Stent Length (mm) |
12, 14, 18, 22 & 30 |
| CAT No |
RSINT25012X, RSINT25014X, RSINT25018X, RSINT25022X & RSINT25030X |
| Catheter Length |
300 cm |
Resolute Integrity is a drug-eluting stent (DES) and balloon catheter that offers excellent deliverability and flexibility for percutaneous coronary interventions.
Precision and Performance in Coronary CareThe Resolute Integrity DES is crafted for optimal coronary artery patency in PCI procedures. Featuring a continuous sinusoidal design for flexibility, high radial strength, and improved vessel conformability, it aims to deliver superior outcomes. Its rapid exchange delivery and enhanced radiopacity ensure accuracy and efficiency during stent implantation.
Innovative Drug-Eluting TechnologyCoated with Zotarolimus using the advanced BioLinx polymer, this stent provides controlled, sustained drug delivery to minimize restenosis. The design is backed by proven materials (cobalt chromium alloy) and industry-leading sterilization for safety and longevity, with a shelf life of two years.
Versatile Options to Suit Clinical NeedsAvailable in a broad spectrum of lengths (8 mm to 38 mm), the 2.50 mm diameter Resolute Integrity SD is tailored for diverse patient anatomies and lesion profiles. Its rapid exchange system enhances procedural workflow, making it a trusted choice in interventional cardiology across India. Single-use and portable, it meets stringent clinical requirements.
FAQ's of Medtronic Resolute Integrity DES Drug-eluting Stent (SD 2.50):
Q: How is the Medtronic Resolute Integrity DES Drug-eluting Stent (SD 2.50) used during a coronary intervention?
A: The Resolute Integrity DES SD 2.50 is deployed via a rapid exchange (RX) delivery system during a percutaneous coronary intervention (PCI). The stent is positioned across the narrowed segment of a coronary artery, then expanded to restore vessel patency and deliver a controlled dose of Zotarolimus to prevent restenosis.
Q: What are the main benefits of the Resolute Integrity SD 2.50 stent compared to traditional bare-metal stents?
A: This drug-eluting stent combines enhanced conformability, high radial strength, and sustained drug release to significantly reduce the risk of restenosis. The BioLinx polymer coating with Zotarolimus further helps maintain vessel clarity by preventing re-narrowing, leading to better long-term outcomes.
Q: When should the Resolute Integrity SD 2.50 stent be considered for use?
A: It is indicated for coronary artery disease patients requiring percutaneous coronary intervention (PCI) to treat significant coronary blockages, particularly where reducing the risk of restenosis is critical. Your physician will determine appropriateness based on individual case requirements.
Q: Where should the stent be stored prior to use to maintain its integrity?
A: The stent should be kept in its original packaging in a cool, dry environment away from direct sunlight. Proper storage ensures that the product maintains sterility and optimal performance up to its indicated expiry date.
Q: What is the process for selecting the appropriate stent length for a patient?
A: Selection of stent length (ranging from 8 mm to 38 mm) depends on the size and extent of the lesion in the coronary artery. The interventional cardiologist assesses angiographic images to match the stent size precisely to the patient's anatomy for best results.
Q: Is the Resolute Integrity SD 2.50 stent MRI safe?
A: Yes, the stent is labeled as MR Conditional, meaning patients who receive it can safely undergo MRI scans under specific conditions. Please consult radiology guidelines and product labeling for detailed recommendations.
Q: What are the usage guidelines and single-use policy for this stent?
A: The Resolute Integrity SD 2.50 is intended for single-use only. It should not be resterilized or reused, as this could compromise patient safety and device performance.